Loxo Oncology develops and markets genomic medicines for the treatment of cancer.
Business Model:
Revenue: $124M
Employees: 201-500
Loxo Oncology was acquired by
Eli Lilly.
The acquisition happend on 2019-01-07.
Details of the transaction were not public
Address: 281 Tresser Blvd
City: Stamford
State: CT
Zip: 06901
Country: US
Loxo Oncology develops and markets genomic medicines for the treatment of cancer.
Contact Phone:
+12036533880
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
8/1/2014
Ticker Symbol:
LOXO
Amount Raised:
$69M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
7/2021 | Kumquat Biosciences | Corporate Round | 70M |
7/2021 | Kumquat Biosciences | Corporate Round | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2013 | Series A | 2 | $33M |
Aisling Capital OrbiMed Aisling Capital OrbiMed Aisling Capital OrbiMed Aisling Capital OrbiMed |
5/2014 | Series B | 3 | $24M |
OrbiMed New Enterprise Associates Aisling Capital New Enterprise Associates OrbiMed New Enterprise Associates Aisling Capital New Enterprise Associates |
4/2014 | Series B | $23.9M |
New Enterprise Associates Aisling Capital OrbiMed Advisors LLC |
5/2016 | Post-IPO Equity | $36M | 1/2017 | Post-IPO Equity | $120M | 7/2014 | IPO | $68.4M |
|
6/2017 | Post-IPO Equity | $226.8M | 11/2015 | Post-IPO Equity | $66.3M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|